Zugriffe: 66700
Who we are
Long term pharma and biotech professionals with a track record of leading projects from research into the market
Our antibody development roots go deep
Our pipeline
Fully human bi- and multi-specific antibodies for the treatment of Alzheimer’s Disease and Antimicrobial Resistant infections
Safe and selective blockade of CD47 on tumors
